Madison Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.32M | Sell |
14,192
-204
| -1% | -$90.8K | 0.07% | 155 |
|
|
2025
Q1 | $6.98M | Sell |
14,396
-126
| -0.9% | -$61.1K | 0.08% | 147 |
|
|
2024
Q4 | $5.85M | Buy |
14,522
+11
| +0.1% | +$4.43K | 0.07% | 157 |
|
|
2024
Q3 | $6.75M | Sell |
14,511
-129
| -0.9% | -$60K | 0.08% | 154 |
|
|
2024
Q2 | $6.86M | Buy |
14,640
+8
| +0.1% | +$3.75K | 0.08% | 151 |
|
|
2024
Q1 | $6.12M | Sell |
14,632
-44
| -0.3% | -$18.4K | 0.08% | 159 |
|
|
2023
Q4 | $5.97M | Sell |
14,676
-338
| -2% | -$138K | 0.08% | 162 |
|
|
2023
Q3 | $5.22M | Sell |
15,014
-213
| -1% | -$74.1K | 0.08% | 161 |
|
|
2023
Q2 | $5.36M | Sell |
15,227
-314
| -2% | -$111K | 0.08% | 160 |
|
|
2023
Q1 | $4.9M | Sell |
15,541
-284
| -2% | -$89.5K | 0.07% | 167 |
|
|
2022
Q4 | $4.57M | Buy |
15,825
+78
| +0.5% | +$22.5K | 0.07% | 174 |
|
|
2022
Q3 | $4.56M | Buy |
15,747
+181
| +1% | +$52.4K | 0.08% | 165 |
|
|
2022
Q2 | $4.39M | Buy |
15,566
+72
| +0.5% | +$20.3K | 0.07% | 173 |
|
|
2022
Q1 | $4.04M | Buy |
15,494
+766
| +5% | +$200K | 0.06% | 193 |
|
|
2021
Q4 | $3.23M | Sell |
14,728
-403
| -3% | -$88.5K | 0.04% | 230 |
|
|
2021
Q3 | $2.75M | Buy |
15,131
+763
| +5% | +$138K | 0.04% | 245 |
|
|
2021
Q2 | $2.9M | Buy |
14,368
+10,533
| +275% | +$2.12M | 0.04% | 248 |
|
|
2021
Q1 | $824K | Buy |
3,835
+435
| +13% | +$93.5K | 0.01% | 269 |
|
|
2020
Q4 | $804K | Buy |
3,400
+400
| +13% | +$94.6K | 0.01% | 258 |
|
|
2020
Q3 | $816K | Hold |
3,000
| – | – | 0.01% | 229 |
|
|
2020
Q2 | $871K | Hold |
3,000
| – | – | 0.02% | 230 |
|
|
2020
Q1 | $714K | Hold |
3,000
| – | – | 0.01% | 225 |
|
|
2019
Q4 | $657K | Buy |
+3,000
| New | +$657K | 0.01% | 252 |
|